Yasuaki Ikemi

Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer

Yosuke Togashi, Katsuhiro Masago, Satohiro Masuda et al. · Cancer Chemotherapy and Pharmacology · 2012 · 283 citations · Full text

Medicine, Oncology, Pharmacology +12

Urinary kidney injury molecule-1 and monocyte chemotactic protein-1 are noninvasive biomarkers of cisplatin-induced nephrotoxicity in lung cancer patients

Haruka Shinke, Satohiro Masuda, Yousuke Togashi et al. · Cancer Chemotherapy and Pharmacology · 2015 · 96 citations · Full text

Medicine, Nephrology, Oncology +13

Population Pharmacokinetics/Pharmacodynamics of Erlotinib and Pharmacogenomic Analysis of Plasma and Cerebrospinal Fluid Drug Concentrations in Japanese Patients with Non-Small Cell Lung Cancer

Masahide Fukudo, Yasuaki Ikemi, Yosuke Togashi et al. · Clinical Pharmacokinetics · 2013 · 87 citations

Medicine, Pharmacokinetics, Pharmacology +15

Efficacy of increased-dose erlotinib for central nervous system metastases in non-small cell lung cancer patients with epidermal growth factor receptor mutation

Yosuke Togashi, Katsuhiro Masago, Masahide Fukudo et al. · Cancer Chemotherapy and Pharmacology · 2011 · 76 citations · Full text

Medicine, Oncology, Pharmacology +17

Pharmacokinetics of Erlotinib and Its Active Metabolite OSI-420 in Patients with Non-small Cell Lung Cancer and Chronic Renal Failure Who Are Undergoing Hemodialysis

Yosuke Togashi, Katsuhiro Masago, Masahide Fukudo et al. · Journal of Thoracic Oncology · 2010 · 55 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +12